Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 233 (TMEM233) is an accessory transmembrane protein primarily expressed in sensory neurons, classified within the dispanin subfamily B family. TMEM233 is required for the pharmacological and toxicological effects of certain plant-derived peptide toxins, notably ExTxA, on the voltage-gated sodium channel NaV1.7, a critical component in nociceptive (pain-sensing) neurons. TMEM233 binds these toxins and, in conjunction with NaV1.7, alters the channel’s inactivation properties, promoting persistent sodium currents and increased cellular excitability. Its structure includes at least one membrane-spanning domain with extracellular C-terminus and intracellular N-terminus. Genetic association studies list TMEM233 in the context of osteogenesis imperfecta type V, but its primary characterized physiological and pathological function relates to pain modulation and sodium channel accessory protein function[1][2][4][5].
Modulation of sodium channel (NaV1.7) gating through physical interaction enabling toxin (ExTxA) action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 233 (TMEM233).